Literature DB >> 12823776

Refining prognostic factors in chronic lymphocytic leukemia.

Francesc Bosch1, Emili Montserrat.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12823776     DOI： 10.1046/j.1468-0734.2002.00302.x

Source DB:  PubMed          Journal:  Rev Clin Exp Hematol        ISSN： 1127-0020


× No keyword cloud information.
  4 in total

1.  miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia.

Authors:  Rosa Visone; Angelo Veronese; Laura Z Rassenti; Veronica Balatti; Dennis K Pearl; Mario Acunzo; Stefano Volinia; Cristian Taccioli; Thomas J Kipps; Carlo M Croce
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

2.  Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.

Authors:  Roberto Marasca; Rossana Maffei; Monica Morselli; Patrizia Zucchini; Ilaria Castelli; Silvia Martinelli; Marcella Fontana; Sara Ravanetti; Monica Curotti; Giovanna Leonardi; Katia Cagossi; Giovanni Partesotti; Giuseppe Torelli
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

3.  Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.

Authors:  A Veronese; F Pepe; J Chiacchia; S Pagotto; P Lanuti; S Veschi; M Di Marco; A D'Argenio; I Innocenti; B Vannata; F Autore; M Marchisio; D Wernicke; F Verginelli; G Leone; L Z Rassenti; T J Kipps; R Mariani-Costantini; L Laurenti; C M Croce; R Visone
Journal:  Leukemia       Date:  2014-04-15       Impact factor: 11.528

4.  Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells.

Authors:  C Pepper; H Lowe; C Fegan; C Thurieau; D E Thurston; J A Hartley; P Delavault
Journal:  Br J Cancer       Date:  2007-06-19       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.